Platform
Features
LUNGevity Foundation
Contact
Dr. Forde’s research examines the role of immunotherapy for earlier-stage lung cancer, and his work has led to the development of several ongoing phase III trials.
29 members
UL Research Institutes
Boston VA Research Institute, Inc. (BVARI)
Carnegie Corporation of New York
American Association of Colleges of Osteopathic Medicine